Drug Type Hematopoietic stem cell therapy |
Synonyms EMD 101, EMD101 |
Target- |
Mechanism Gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neutropenia | Preclinical | US | Emendo Biotherapeutics, Inc.Startup | 16 Jul 2022 |